(JHX) James Hardie Industries - Overview
Exchange: NYSE •
Country: Ireland •
Currency: USD •
Type: Common Stock •
ISIN: US47030M1062
Stock:
Total Rating 39
Risk 58
Buy Signal 0.23
| Risk 5d forecast | |
|---|---|
| Volatility | 43.2% |
| Relative Tail Risk | -14.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.15 |
| Alpha | -41.05 |
| Character TTM | |
|---|---|
| Beta | 1.252 |
| Beta Downside | 0.839 |
| Drawdowns 3y | |
|---|---|
| Max DD | 60.26% |
| CAGR/Max DD | 0.10 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 103.7917
Description: JHX James Hardie Industries
James Hardie Industries plc engages in the manufacture and sale of fiber cement, fiber gypsum, and cement bonded boards in the United States, Australia, Europe, and New Zealand. It operates in three segments: North America Fiber Cement, Asia Pacific Fiber Cement, and Europe Building Products. The company offers fiber cement interior linings, exterior siding products, and related accessories. Its fiber cement products are used for a range of external applications, including siding, cladding, trim, soffit, as well as internal applications such as walls, floors, and ceilings. The company also provides fiber gypsum and cement-bonded boards for interior applications, such as dry lining walls, walls in timber frame buildings, and flooring solutions. Its cement-bonded boards are used in exterior and industrial applications, as well as for fire protection. The company offers its products under the HardieTM brand, such as Hardie Plank, Hardie Panel, Hardie Trim, Hardie Backer, Hardie Artisan Siding, and HardieTM Architectural Collection brands, as well as the fermacell and AESTUVER brands. James Hardie Industries plc was founded in 1888 and is headquartered in Dublin, Ireland.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 119.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -6.01 > 1.0 |
| NWC/Revenue: 13.74% < 20% (prev 20.60%; Δ -6.86% < -1%) |
| CFO/TA 0.04 > 3% & CFO 600.1m > Net Income 119.1m |
| Net Debt (4.60b) to EBITDA (797.3m): 5.77 < 3 |
| Current Ratio: 1.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (583.1m) vs 12m ago 35.32% < -2% |
| Gross Margin: 35.86% > 18% (prev 0.39%; Δ 3546 % > 0.5%) |
| Asset Turnover: 47.06% > 50% (prev 79.68%; Δ -32.62% > 0%) |
| Interest Coverage Ratio: 2.23 > 6 (EBITDA TTM 797.3m / Interest Expense TTM 182.4m) |
Altman Z'' 1.30
| A: 0.04 (Total Current Assets 1.72b - Total Current Liabilities 1.11b) / Total Assets 13.80b |
| B: 0.13 (Retained Earnings 1.80b / Total Assets 13.80b) |
| C: 0.04 (EBIT TTM 407.4m / Avg Total Assets 9.36b) |
| D: 0.28 (Book Value of Equity 2.09b / Total Liabilities 7.41b) |
| Altman-Z'' Score: 1.30 = BB |
Beneish M -1.95
| DSRI: 1.04 (Receivables 316.8m/270.6m, Revenue 4.40b/3.91b) |
| GMI: 1.10 (GM 35.86% / 39.45%) |
| AQI: 2.51 (AQ_t 0.63 / AQ_t-1 0.25) |
| SGI: 1.13 (Revenue 4.40b / 3.91b) |
| TATA: -0.03 (NI 119.1m - CFO 600.1m) / TA 13.80b) |
| Beneish M-Score: -1.95 (Cap -4..+1) = B |
What is the price of JHX shares?
As of February 26, 2026, the stock is trading at USD 24.75 with a total of 4,249,280 shares traded.
Over the past week, the price has changed by -1.51%, over one month by +1.60%, over three months by +29.31% and over the past year by -21.03%.
Over the past week, the price has changed by -1.51%, over one month by +1.60%, over three months by +29.31% and over the past year by -21.03%.
Is JHX a buy, sell or hold?
James Hardie Industries has received a consensus analysts rating of 4.50.
Therefore, it is recommended to buy JHX.
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the JHX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 29.9 | 20.9% |
| Analysts Target Price | 29.9 | 20.9% |
JHX Fundamental Data Overview February 21, 2026
P/E Trailing = 103.7917
P/E Forward = 31.25
P/S = 3.2806
P/B = 2.2583
P/EG = 1.1439
Revenue TTM = 4.40b USD
EBIT TTM = 407.4m USD
EBITDA TTM = 797.3m USD
Long Term Debt = 4.57b USD (from longTermDebt, last quarter)
Short Term Debt = 80.8m USD (from shortTermDebt, last quarter)
Debt = 4.97b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.60b USD (from netDebt column, last quarter)
Enterprise Value = 19.08b USD (14.45b + Debt 4.97b - CCE 344.2m)
Interest Coverage Ratio = 2.23 (Ebit TTM 407.4m / Interest Expense TTM 182.4m)
EV/FCF = 92.66x (Enterprise Value 19.08b / FCF TTM 205.9m)
FCF Yield = 1.08% (FCF TTM 205.9m / Enterprise Value 19.08b)
FCF Margin = 4.68% (FCF TTM 205.9m / Revenue TTM 4.40b)
Net Margin = 2.70% (Net Income TTM 119.1m / Revenue TTM 4.40b)
Gross Margin = 35.86% ((Revenue TTM 4.40b - Cost of Revenue TTM 2.82b) / Revenue TTM)
Gross Margin QoQ = 36.15% (prev 32.59%)
Tobins Q-Ratio = 1.38 (Enterprise Value 19.08b / Total Assets 13.80b)
Interest Expense / Debt = 1.32% (Interest Expense 65.6m / Debt 4.97b)
Taxrate = 37.88% (41.9m / 110.6m)
NOPAT = 253.1m (EBIT 407.4m * (1 - 37.88%))
Current Ratio = 1.54 (Total Current Assets 1.72b / Total Current Liabilities 1.11b)
Debt / Equity = 0.78 (Debt 4.97b / totalStockholderEquity, last quarter 6.40b)
Debt / EBITDA = 5.77 (Net Debt 4.60b / EBITDA 797.3m)
Debt / FCF = 22.34 (Net Debt 4.60b / FCF TTM 205.9m)
Total Stockholder Equity = 4.28b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.27% (Net Income 119.1m / Total Assets 13.80b)
RoE = 2.78% (Net Income TTM 119.1m / Total Stockholder Equity 4.28b)
RoCE = 4.60% (EBIT 407.4m / Capital Employed (Equity 4.28b + L.T.Debt 4.57b))
RoIC = 3.33% (NOPAT 253.1m / Invested Capital 7.60b)
WACC = 8.04% (E(14.45b)/V(19.42b) * Re(10.53%) + D(4.97b)/V(19.42b) * Rd(1.32%) * (1-Tc(0.38)))
Discount Rate = 10.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 15.34%
[DCF] Terminal Value 77.43% ; FCFF base≈270.7m ; Y1≈261.7m ; Y5≈258.8m
[DCF] Fair Price = N/A (negative equity: EV 4.54b - Net Debt 4.60b = -56.9m; debt exceeds intrinsic value)
EPS Correlation: -61.85 | EPS CAGR: -12.61% | SUE: 0.14 | # QB: 0
Revenue Correlation: 49.09 | Revenue CAGR: 6.82% | SUE: 0.06 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.29 | Chg7d=+0.003 | Chg30d=+0.003 | Revisions Net=+0 | Analysts=3
EPS next Year (2027-03-31): EPS=1.25 | Chg7d=+0.055 | Chg30d=+0.062 | Revisions Net=+1 | Growth EPS=+13.4% | Growth Revenue=+15.0%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.6% (Discount Rate 10.5% - Earnings Yield 1.0%)
[Growth] Growth Spread = +47.5% (Analyst 57.0% - Implied 9.6%)
P/E Forward = 31.25
P/S = 3.2806
P/B = 2.2583
P/EG = 1.1439
Revenue TTM = 4.40b USD
EBIT TTM = 407.4m USD
EBITDA TTM = 797.3m USD
Long Term Debt = 4.57b USD (from longTermDebt, last quarter)
Short Term Debt = 80.8m USD (from shortTermDebt, last quarter)
Debt = 4.97b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.60b USD (from netDebt column, last quarter)
Enterprise Value = 19.08b USD (14.45b + Debt 4.97b - CCE 344.2m)
Interest Coverage Ratio = 2.23 (Ebit TTM 407.4m / Interest Expense TTM 182.4m)
EV/FCF = 92.66x (Enterprise Value 19.08b / FCF TTM 205.9m)
FCF Yield = 1.08% (FCF TTM 205.9m / Enterprise Value 19.08b)
FCF Margin = 4.68% (FCF TTM 205.9m / Revenue TTM 4.40b)
Net Margin = 2.70% (Net Income TTM 119.1m / Revenue TTM 4.40b)
Gross Margin = 35.86% ((Revenue TTM 4.40b - Cost of Revenue TTM 2.82b) / Revenue TTM)
Gross Margin QoQ = 36.15% (prev 32.59%)
Tobins Q-Ratio = 1.38 (Enterprise Value 19.08b / Total Assets 13.80b)
Interest Expense / Debt = 1.32% (Interest Expense 65.6m / Debt 4.97b)
Taxrate = 37.88% (41.9m / 110.6m)
NOPAT = 253.1m (EBIT 407.4m * (1 - 37.88%))
Current Ratio = 1.54 (Total Current Assets 1.72b / Total Current Liabilities 1.11b)
Debt / Equity = 0.78 (Debt 4.97b / totalStockholderEquity, last quarter 6.40b)
Debt / EBITDA = 5.77 (Net Debt 4.60b / EBITDA 797.3m)
Debt / FCF = 22.34 (Net Debt 4.60b / FCF TTM 205.9m)
Total Stockholder Equity = 4.28b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.27% (Net Income 119.1m / Total Assets 13.80b)
RoE = 2.78% (Net Income TTM 119.1m / Total Stockholder Equity 4.28b)
RoCE = 4.60% (EBIT 407.4m / Capital Employed (Equity 4.28b + L.T.Debt 4.57b))
RoIC = 3.33% (NOPAT 253.1m / Invested Capital 7.60b)
WACC = 8.04% (E(14.45b)/V(19.42b) * Re(10.53%) + D(4.97b)/V(19.42b) * Rd(1.32%) * (1-Tc(0.38)))
Discount Rate = 10.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 15.34%
[DCF] Terminal Value 77.43% ; FCFF base≈270.7m ; Y1≈261.7m ; Y5≈258.8m
[DCF] Fair Price = N/A (negative equity: EV 4.54b - Net Debt 4.60b = -56.9m; debt exceeds intrinsic value)
EPS Correlation: -61.85 | EPS CAGR: -12.61% | SUE: 0.14 | # QB: 0
Revenue Correlation: 49.09 | Revenue CAGR: 6.82% | SUE: 0.06 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.29 | Chg7d=+0.003 | Chg30d=+0.003 | Revisions Net=+0 | Analysts=3
EPS next Year (2027-03-31): EPS=1.25 | Chg7d=+0.055 | Chg30d=+0.062 | Revisions Net=+1 | Growth EPS=+13.4% | Growth Revenue=+15.0%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.6% (Discount Rate 10.5% - Earnings Yield 1.0%)
[Growth] Growth Spread = +47.5% (Analyst 57.0% - Implied 9.6%)